Skip to main content

Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells

Chinese Journal of Integrative Medicine volume 22, pages 276–283 (2016)Cite this article

Abstract

Objective

To observe the effects of Danhong Injection (丹红注射液) and its main components, including daiclzein and hydroxysafflor yellow A (HSYA), on the anticoagulation, fibrinolysis, anti-apoptosis in hypoxia model of vein endothelial cells (VECs).

Methods

VECs were prepared and were put in a hypoxia environment, which consisted of mixed gas of 95% N and 5% CO mixed gas, when reached confluent culture. Five groups used different treatments, including normal control group, hypoxia group, daiclzein group, HSYA group and Danhong Injection group. The VECs were identified by fluorescence double labeling methods. The morphology was observed by a phase contrast microscopy. The effects of Danhong Injection, daiclzein and HSYA on 6 keto prostaglandin F1α (6-keto-PGF1α) level was measured by the method of radioimmunoassay (RIA). Superoxide dismutase (SOD) activity was tested by water soluble tetrazolium salt. The content of malondialdehyde (MDA) was measured by thiobarbituric acid. The activities of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI) were measured by the method of chromogenic substrate. The contents of endothelin (ET) and nitric oxide (NO) were detected by non-equilibrium RIA and enzymelinked immunosorbent assay. Cells apoptosis rate was determined by flow cytometry.

Results

Compared with the normal control group, the floating cells number, PAI activity, ET and MDA contents, and cells apoptosis rate in the culture solution of hypoxia group were all significantly increased, whereas the 6-keto-PGF1α and NO contents, and t-PA and SOD activities were decreased significantly (P<0.01). Compared with the hypoxia group, Danhong Injection markedly increased the 6-keto-PGF1α content and SOD activity, regulated PAI and t-PA activities, ET and NO contents, and decreased MDA content and cells apoptosis rate (P<0.05 or P<0.01).

Conclusions

Danhong Injection and its main components played an important role in protecting primary VECs from hypoxic damage by regulating the secretion and vasomotor function of VECs. The function of Danhong Injection was most remarkable.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Wang X, Xiong JW. Vascular endothelial cell developmentand underlying mechanisms. Hereditas 2012;34:1114–1122.

    CAS  PubMed  Google Scholar 

  2. Chen Q, Zhuang Q, Mao W, Xu XM, Wang LH, Wang HB. Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/ß-catenin signaling pathway in human umbilical vein endothelial cells. Chin J Integr Med 2014;20:743–750.

    Article  PubMed  Google Scholar 

  3. Wang M, Lei Y. Time-effect relationship of extracts from Ginseng, Notoginseng and Chuanxiong on vascular endothelial cells senescence. Chin J Integr Med 2014;20:758–763.

    Article  PubMed  Google Scholar 

  4. Liang JQ, Xu HB, Wu YL, Sun SR, Jia ZH, Wei C, et al. Effect of serum from overfatigue rats on JNK/c-Jun/HO-1 pathway in human umbilical vein endothelial cells and the intervening effect of Tongxinluo Superfi ne Powder. Chin J Integr Med 2009;15:121–127.

    Article  PubMed  Google Scholar 

  5. Chen Q, Yi D, Xie Y, Yang W, Zhuang Y, Du J. Analysis of clinical use of Danhong Injection based on hospital information system. China J Chin Mater Med (Chin) 2011;36:2817–2820.

    Google Scholar 

  6. Li HM. Clinical observation on Danhong Injection in treating acute cerebral Infarction. China J Chin Med 2011;26:1234–1235.

    Google Scholar 

  7. Wang JW, Shi WG, Bi JT. Effects of Danhong Injection on the inflammatory reactants and fibrinolytic activity in unstable angina. Chin J Integr Med Cardio/Cerebrovasc Dis 2007;5:673–675.

    Google Scholar 

  8. Ma XJ, Yin SJ, Jin JC, Wu CF, Huang Y, Shi DZ, et al. Synergistic protection of Danhong Injection and ischemic postconditioning on myocardial reperfusion injury in minipigs. Chin J Integr Med 2010;16:531–536.

    Article  PubMed  Google Scholar 

  9. You HL, Wang B, Xu LH. Content determination of 4 kinds of water-soluble ingredients in Danhong Injection by HPLC. Chin Pharm Affairs (Chin) 2012;26:743–746.

    CAS  Google Scholar 

  10. Zhou JF, Zhou P, Lu CX. Content determination of hydroxysafflor yellow A in Danhong Injection by HPLC. J Mod Med Health (Chin) 2013;29:658–659.

    Google Scholar 

  11. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arterioscler Thromb Vascul Biol 2005;25:29–38.

    CAS  Article  Google Scholar 

  12. Tai MH, Liu LM, Ma RQ, Li X, Pang JX, Xu JP. General pharmacology of Danhong Injection. J First Milit Med Univ (Chin) 2005;25:335–338.

    Google Scholar 

  13. Luo JM, Xiao X, Liang QL, Luo GA, Wang YM. Fingerprint chromatography of Danhong Injection by HPLC. Chin Tradit Patent Med (Chin) 2011;8:1277–1280.

    Article  Google Scholar 

  14. Nachman RL, Jaffe EA. Endothelial cell culture: beginnings of modern vascular biology. J Clin Invest 2004;114:1037–1040.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  15. Dal Monte M, Martini D, Ristori C, Azara D, Armani C, Balbarini A, et al. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Naunyn-Schmiedeberg's Arch Pharmacol 2011;383:593–612.

    CAS  Article  Google Scholar 

  16. Li SM. Angiotensin-?-induced human umbilical vein endothelial ce1ls and human umbilical arterial smooth muscle cells the expreßsion of integrin ß3 research [dissertation]. Beijing: Peking Union Medical College; 2003.

    Google Scholar 

  17. Vasques E, Almeida AL, Noya V, D'Alegria B, Marathe G, McIntyre TM, et al. Impairment of endothelium-dependent aorta relaxation by phospholipid components of oxidized low-density lipoprotein. Endothelium 2006;13:1–8.

    CAS  Article  PubMed  Google Scholar 

  18. Maiti P, Singh SB, Sharma AK, Muthuraju S, Banerjee PK, Ilavazhagan G. Hypobaric hypoxia induces oxidative stress in rat brain. Neurochem Int 2006;49:709–716.

    CAS  Article  PubMed  Google Scholar 

  19. He J, Gu D, Chen J, Wu X, Kelly TN, Huang JF, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet 2009;374:1765–1772.

    Article  PubMed  Google Scholar 

  20. Cokic BB, Cokic VP, Suresh S, Wirt S, Noguchi CT. Nitric oxide and hypoxia stimulate and regulate erythropoietin receptor in endothelial cells. Microvasc Res 2014;92:34–40.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. Bai J, Chi G, Zhang J, Liu LN, Fan M, Liu HD, et al. Protective effect of carnosine on the injury of rat vascular endothelial cells induced by hypoxia. Chin J Appl Physiol (Chin) 2010;26:30–32.

    CAS  Google Scholar 

  22. Qiao W, Niu L, Liu Z, Qiao T, Liu C. Endothelial nitric oxide synthase as a marker for human endothelial progenitor cells. Tohoku J Exp Med 2010;221:19–27.

    CAS  Article  PubMed  Google Scholar 

  23. Aicher A, Heeschen C, Mildner R. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003;9:1370–1376.

    CAS  Article  PubMed  Google Scholar 

  24. Pawar A, Nanduri J, Yuan G, Khan SA, Wang N, Kumar GK, et al. Reactive oxygen species-dependent endothelin signaling is required for augmented hypoxie sensory response of the neonatal carotid body by intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 2009;296:735–742.

    Article  Google Scholar 

  25. Geto K, Hama H, Kasuya Y. Molecular pharmacology and patho-physiological significance of endothelin. Jpn J Pharmacol 1996;72:261–290.

    Article  Google Scholar 

  26. Suzuki Y, Urano T. Secretory dynamics of t-PA and its modulation by PAI-1 in vascular system. Rinsho Ketsueki 2009;50:399–403.

    PubMed  Google Scholar 

  27. Singh P, Peterson TE, Barber KR, Kuniyoshi FS, Jensen A, Hoffmann M, et al. Leptin upregulates the expression of plasminogen activator ingibitor-1 in human vascular endothelial cells. Biochem Biophys Res Commun 2010;392:47–52.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. Stitham J, Midgett C, Martin KA, Hwa J. Prostacyclin: an infl ammatory paradox. Front Pharmacol 2011;2:24–32.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. Haastrup A, Gadegbeku CA, Zhang D, Mukhin YV, Greene EL, Jaffa AA, et al. Lipids stimulate the prodaction of 6-keto-prostaglandin F [1alpha] in human dorsal hand veins. Hypertension 2001;38:858–863.

    CAS  Article  PubMed  Google Scholar 

  30. Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol 2015;6:365–376.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Lubrano V, Balzan S. Enzymatic antioxidant system in vascular infl ammation and coronary artery disease. World J Experiment Med 2015;5:218–224.

    Article  Google Scholar 

  32. Han N, Ding SJ, Wu T, Zhu YL. Correlation of free radicalleveland apoptosis after intracerebral hemorrhage in rats. Neumsei Bull 2008;24:351–358.

    CAS  Google Scholar 

  33. Pollak J, Doyle KP, Mamer L, Shamloo M, Buckwalter MS. Stratification substantially reduces behavioral variability in the hypoxic-ischemic stroke model. Brain Behavior 2012;2:698–706.

    Article  PubMed  PubMed Central  Google Scholar 

  34. He Y, Wan H, Du Y, Bie X, Zhao T, Fu W, et al. Protective effect of Danhong Injection on cerebral ischemia-reperfusion injury in rats. J Ethnopharmacol 2012;144:387–394.

    CAS  Article  PubMed  Google Scholar 

  35. Murdoch J, Hall R. Brain protection: physiological and pharmacological considerations. Part ?: the physiology of brain injury. Canad J Anaesth 1990;37:663–671.

    CAS  Google Scholar 

  36. Guo R, Zhao GF, Feng Z, Hao LL. Effect of Danhong Injection on serum matrix metalloproteinase-9 (MMP-9) and its clinical effi cacy in patients with cerebral infarction. Chin J Pract Nervous Dis (Chin) 2010;24:17–19.

    Google Scholar 

  37. Liu J, Zhang B. Centralized monitoring and analysis on 400 cases of Danhong Injection treatments. Int J Tradit Chin Med 2011;33:701–703.

    CAS  Google Scholar 

  38. Matijevic N, Wu KK. Hypercoagulable states and strokes. Current Atherosclerosis Reports 2006;8:324–329.

    CAS  Article  PubMed  Google Scholar 

  39. Jaffer H, Morris V.B, Stewart D, Labhasetwar V. Advances in stroke therapy. Drug Delivery Translat Res 2011;1:409–419.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Research Institution of Cardio-Cerebral-Vascular Disease, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310053, China

    Yu-yan Zhang, Hui-fen Zhou, Jie-hong Yang & Hai-tong Wan

  2. Pharmaceutical College, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310053, China

    Yu He & Hao-fang Wan

  3. School of Food and Pharmaceutical Engineering, Hubei University of Technology, Wuhan, 430068, China

    Xiao-qiang Chen & Nishinari Katsuyoshi

Authors
  1. Yu-yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hui-fen Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie-hong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiao-qiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nishinari Katsuyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hao-fang Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hai-tong Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hai-tong Wan.

Additional information

Supported by the National Natural Science Foundation of China (No. 81173647, 81473587, 81274176), Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents, and Key Discipline of Zhejiang Traditional Chinese Medicine (Integrated Traditional and Western Medicine, No. 2012-XK-A06)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, Yy., Zhou, Hf., Yang, Jh. et al. Effects of Danhong Injection (丹红注射液) and its main components on anticoagulation and fibrinolysis in cultured vein endothelial cells. Chin. J. Integr. Med. 22, 276–283 (2016). https://doi.org/10.1007/s11655-016-2498-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2498-x

Keywords

  • vein endothelial cells
  • Danhong Injection
  • daiclzein
  • hydroxysafflor yellow A
  • anticoagulation
  • fibrinolysis
  • Chinese medicine